• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number M0068505110
Device Problems Material Integrity Problem (2978); Adverse Event Without Identified Device or Use Problem (2993); Positioning Problem (3009)
Patient Problems Erosion (1750); Pain (1994); Scar Tissue (2060); Complaint, Ill-Defined (2331); No Code Available (3191); Dyspareunia (4505); Insufficient Information (4580)
Event Date 12/14/2016
Event Type  Injury  
Manufacturer Narrative
Date of event was approximated to (b)(6) 2016, implant date, as no event date was reported.(b)(6) the revision surgery was performed by (b)(6) at (b)(6) hospital.(b)(4).The excised mesh is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an obtryx ii system - halo device was implanted into the patient during a vaginal repair and obtryx sling placement procedure for stress urinary incontinence performed on (b)(6) 2016.As reported by the patient's attorney, the mesh eroded through the patient's anterior vaginal wall and was seen to extend laterally approximately 26mm on either side of the bladder neck.On (b)(6) 2016, the patient underwent mesh excision due to dyspareunia, pain, and mesh erosion.After the mesh excision, the patient still experiences occasional peroneal posterior coccygeal pain.It was also reported that the patient had "nerve/scar tissue/etc." boston scientific has been unable to obtain additional information regarding the event to date.
 
Event Description
It was reported to boston scientific corporation that an obtryx ii system - halo device was implanted into the patient during a vaginal repair and obtryx sling placement procedure for stress urinary incontinence performed on (b)(6) 2016.As reported by the patient's attorney, the mesh eroded through the patient's anterior vaginal wall and was seen to extend laterally approximately 26mm on either side of the bladder neck.On (b)(6) 2016, the patient underwent mesh excision due to dyspareunia, pain, and mesh erosion.After the mesh excision, the patient still experiences occasional peroneal posterior coccygeal pain.It was also reported that the patient had "nerve/scar tissue/etc." **additional information received on november 28, 2022: on (b)(6) 2017, the patient underwent removal of obtryx sling and cystoscopy.During the surgery, it was discovered that the right arm of the sling was bunched up and tight.It was then removed in two pieces.The left arm was removed easily in one piece.Diagnoses at that time included mesh sling exposure across the right vaginal sulcus and pelvic and groin pain.On cystoscopy, there was no mesh noted in the bladder or urethra.
 
Manufacturer Narrative
Blocks b5 and h6 device codes have been updated based on the additional information received on november 28, 2022.Correction to block b3, section e and block g2.Block g2: company representative has been removed as the event was reported by the patient's legal representation.Block b3: the exact event onset date is unknown.The provided event date of (b)(6) 2016 was chosen as a best estimate based on the date of the first revision surgery.Block e1: this complaint was received as litigation from a legal source in australia.The implant surgeon is: (b)(6).The revision surgery (december 2016) was performed by dr.(b)(6).The second revision surgery (september 2017) was performed by (b)(6).Block h6: the following imdrf patient codes capture the reportable events below: e1405 - dyspareunia, e2006 - mesh erosion, e1715 - scar tissue, e2401 - undescribed patient complications, e2330 - pain.Impact code f1905 captures the reportable event of mesh revision surgeries.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBTRYX II SYSTEM - HALO
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
FREUDENBERG MEDICAL MIS INC
2301 centennial boulevard
jeffersonville IN 47130
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key11138593
MDR Text Key225732743
Report Number3005099803-2020-06590
Device Sequence Number1
Product Code OTN
UDI-Device Identifier08714729839279
UDI-Public08714729837565
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K121754
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/11/2019
Device Model NumberM0068505110
Device Catalogue Number850-511
Device Lot NumberML00003562
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/11/2020
Initial Date FDA Received01/08/2021
Supplement Dates Manufacturer Received11/28/2022
Supplement Dates FDA Received12/15/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/11/2016
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age47 YR
Patient SexFemale
-
-